VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AORTArtivion, Inc.
$21.19$1.0B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. AORT
  3. Financial Ratios

Artivion, Inc. (AORT) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Devices

View Quarterly Ratios →

P/E Ratio
100.90
↓-54% vs avg
5yr avg: 217.19
082%ile100
30Y Low8.6·High174.1
View P/E History →
EV/EBITDA
↑
25.52
↓-25% vs avg
5yr avg: 34.02
046%ile100
30Y Low6.7·High88.9
P/FCF
↑
N/A
—
5yr avg: 85.89
30Y Low9.4·High177.3
P/B Ratio
↑
2.23
↓-31% vs avg
5yr avg: 3.21
033%ile100
30Y Low1.1·High13.0
ROE
↑
2.7%
↓+156% vs avg
5yr avg: -4.8%
050%ile100
30Y Low-50%·High41%
Debt/EBITDA
↓
5.94
↓-38% vs avg
5yr avg: 9.57
065%ile100
30Y Low0.0·High13.7

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

AORT Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

Artivion, Inc. trades at 100.9x earnings, 54% below its 5-year average of 217.2x, sitting at the 82nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 356%.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$1.0B$2.2B$1.2B$728M$485M$793M$894M$1.0B$1.0B$654M$629M
Enterprise Value$1.3B$2.4B$1.5B$1.0B$803M$1.1B$1.1B$1.2B$1.2B$840M$643M
P/E Ratio →100.90217.19—————600.67—174.0959.84
P/S Ratio2.334.873.072.061.552.653.533.713.933.453.48
P/B Ratio2.234.804.312.591.712.642.723.593.762.343.01
P/FCF——107.8563.93——177.33132.25252.35173.9051.12
P/OCF26.9856.4153.5938.70——72.2764.80104.5860.5631.87

P/E links to full P/E history page with 30-year chart

AORT EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

Artivion, Inc.'s enterprise value stands at 25.5x EBITDA, 25% below its 5-year average of 34.0x. The Healthcare sector median is 14.2x, placing the stock at a 80% premium on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—5.393.862.902.563.684.544.484.624.433.56
EV / EBITDA25.5248.3323.7835.6728.0234.2849.6634.9844.3547.4421.28
EV / EBIT46.9588.9256.06276.83247.74534.14—74.83100.3599.4938.02
EV / FCF——135.8090.20——228.10159.51296.81223.2552.28

AORT Profitability

Margins and return-on-capital ratios measuring operating efficiency

Artivion, Inc. earns an operating margin of 6.1%. Operating margins have expanded from 1.6% to 6.1% over the past 3 years, signaling improving operational efficiency. ROE of 2.7% is modest. ROIC of 3.2% represents below-average returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin61.3%61.3%64.0%64.7%64.5%66.1%66.3%66.3%65.8%67.8%65.9%
Operating Margin6.1%6.1%10.0%1.6%2.0%2.7%1.0%6.2%3.5%4.2%12.1%
Net Profit Margin2.2%2.2%-3.4%-8.7%-6.1%-5.0%-6.6%0.6%-1.4%2.0%6.0%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE2.7%2.7%-4.8%-10.8%-6.6%-4.7%-5.4%0.6%-1.4%1.5%5.9%
ROA1.2%1.2%-1.7%-3.9%-2.5%-1.9%-2.4%0.3%-0.7%0.8%4.3%
ROIC3.2%3.2%5.0%0.7%0.8%1.0%0.3%2.7%1.5%1.7%9.8%
ROCE3.6%3.6%5.3%0.8%0.8%1.1%0.4%3.1%1.7%1.9%9.7%

AORT Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

Artivion, Inc. carries a Debt/EBITDA ratio of 5.9x, which is highly leveraged (85% above the sector average of 3.2x). Net debt stands at $227M ($292M total debt minus $65M cash). Interest coverage of just 1.0x is concerning — the company has limited headroom to absorb earnings volatility before struggling with debt service.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.650.651.311.271.251.200.970.860.810.810.34
Debt / EBITDA5.945.945.7412.4312.4611.2813.716.938.1612.792.37
Net Debt / Equity—0.511.121.061.121.020.780.740.660.670.07
Net Debt / EBITDA4.624.624.9010.3911.089.5711.065.986.6410.490.47
Debt / FCF——27.9526.27——50.7827.2644.4649.341.16
Interest Coverage1.011.010.780.150.180.12-0.031.110.771.735.56

AORT Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

Artivion, Inc.'s current ratio of 2.99x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.08x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 4.85x to 2.99x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.992.994.344.854.985.513.884.155.194.184.89
Quick Ratio2.082.083.153.433.483.802.672.973.873.094.02
Cash Ratio0.640.640.801.020.791.221.020.751.200.951.90
Asset Turnover—0.500.490.450.410.380.320.460.460.320.57
Inventory Turnover1.851.851.751.521.491.321.171.761.981.312.34
Days Sales Outstanding—85.7580.6976.4480.9470.9770.2773.8171.4298.9860.90

AORT Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Artivion, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 1.0% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield1.0%0.5%—————0.2%—0.6%1.7%
FCF Yield——0.9%1.6%——0.6%0.8%0.4%0.6%2.0%
Buyback Yield0.0%0.0%0.0%0.1%0.4%0.2%0.2%0.3%0.2%0.2%0.1%
Total Shareholder Yield0.0%0.0%0.0%0.1%0.4%0.2%0.2%0.3%0.2%0.2%0.1%
Shares Outstanding—$47M$42M$41M$40M$39M$38M$38M$36M$34M$33M

Peer Comparison

Compare AORT with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
AORT logoAORTYou$1B100.925.5—61.3%6.1%2.7%3.2%5.9
NVCR logoNVCR$2B-11.7——74.5%-23.5%-38.9%-16.4%—
ATRC logoATRC$1B-120.080.730.274.4%-0.6%-2.4%-0.6%5.2
NNOX logoNNOX$109M-1.8——-94.0%-502.9%-27.8%-27.9%—
TMDX logoTMDX$3B16.219.920.459.9%17.9%54.2%18.8%3.5
MASI logoMASI$9B-64.328.047.661.9%20.5%-17.1%16.5%1.6
GMED logoGMED$11B20.217.118.167.4%16.3%12.3%8.9%0.2
LMAT logoLMAT$2B37.329.328.771.5%27.2%15.8%9.7%2.4
ANGO logoANGO$505M-14.6——53.9%-13.7%-17.5%-22.9%—
MDT logoMDT$102B22.014.519.665.3%17.8%9.4%6.0%3.2
EW logoEW$50B47.726.837.778.1%27.0%10.5%15.5%0.4
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

AORT — Frequently Asked Questions

Quick answers to the most common questions about buying AORT stock.

What is Artivion, Inc.'s P/E ratio?

Artivion, Inc.'s current P/E ratio is 100.9x. The historical average is 60.0x. This places it at the 82th percentile of its historical range.

What is Artivion, Inc.'s EV/EBITDA?

Artivion, Inc.'s current EV/EBITDA is 25.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 31.2x.

What is Artivion, Inc.'s ROE?

Artivion, Inc.'s return on equity (ROE) is 2.7%. The historical average is -0.4%.

Is AORT stock overvalued?

Based on historical data, Artivion, Inc. is trading at a P/E of 100.9x. This is at the 82th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Artivion, Inc.'s profit margins?

Artivion, Inc. has 61.3% gross margin and 6.1% operating margin.

How much debt does Artivion, Inc. have?

Artivion, Inc.'s Debt/EBITDA ratio is 5.9x, indicating high leverage. A ratio above 4x may signal elevated financial risk.